Share Name Share Symbol Market Type Share ISIN Share Description
Collagen Sol LSE:COS London Ordinary Share GB00B94T6Y14 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 4.50p 4.25p 4.75p 4.50p 4.50p 4.50p 30,000 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3.9 -1.6 -1.0 - 14.60

Collagen Sol Share Discussion Threads

Showing 576 to 600 of 600 messages
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
28/9/2017
14:34
Investor presentation by Collagen Solutions CEO Jamal Rushdy at the Hardman & Co’s Investors Forum 20th September 2017. Http://www.piworld.co.uk/2017/09/27/collagen-solutions-cos-hardman-cos-investor-forum-presentation-september-2017/ Collagen Solutions develops, manufactures and supplies medical grade collagen biomaterials for use in research, medical devices, and regenerative medicine. Introduction – 00:20 Regenerative medicine – 00:44 What Collagen Solutions do: 2:17 How will Collagen Solutions Grow? – 4:12 About collagen and tissue biomaterials – 7:00 Growing the core biomaterials business – 8:32 The competition – 12:00 Collagen Solution’s USP – 13:05 Proprietary products pipeline – 15:04 Financial Highlights – 18:36 Growth & investor proposition – 19:00 Q&A Knee surgery recovery – 19:45 The regulatory process – 20:28 Demand & supply of collagen – 21:41 Why bovine tissue? & immune reaction? – 22:50
tomps2
25/9/2017
09:52
Thanks tim. CE mark nailed on. Timescale after operation study and stats no one in the world can match. Very happy to watch this one build... whilst being invested, I bought a portion slightly higher like others, but I've also averaged down considerably. DYOR
jacobjohn7
22/9/2017
01:23
Collagen Solutions were at the Hardman Conference last night, Jamal had a 20 min slot followed by Q&As, he talked about this extended trial and was emphasising its importance, a couple of the Q&As at the end were on the extended study too. It was recorded on video, so it should be available on the Hardman web site shortly, there is also a new Hardman research report updated to reflect recent progress on their web site too http://www.hardmanandco.com/docs/default-source/company-docs/collagen-solutions-plc-documents/21.09.17-engineering-towards-ce-mark.pdf
timbo003
21/9/2017
18:32
Glad you said that inter I feel exactly the same. I bought at 7p but my waiting has turned me into a skeleton.
1toad
21/9/2017
08:30
I admire such consistent and patient enthusiasm. I am 60% down on my investment and i'm getting a bit tired of these jam tomorrow announcements and still the share price goes nowhere.
interstellar
21/9/2017
08:08
Positive announcement again this morning. If they can get CE mark, that's a large market for them to aim at.
18bt
30/8/2017
20:36
anyone get any titbits from agm?
jacobjohn7
23/8/2017
14:08
Any thoughts on timings etc for the CE mark etc? They could be waiting to make an impact at the AGM?
jacobjohn7
28/7/2017
09:17
you mean figures wise dan? When the inhouse products get approval and release we will move.
jacobjohn7
26/7/2017
21:15
Link to Hardman report (dated July 25th 2017) referred to above: http://www.hardmanandco.com/docs/default-source/company-docs/collagen-solutions-plc-documents/cos---2017-results---25-july-2017.pdf
timbo003
26/7/2017
11:16
The report from Hardman was slightly less positive than their previous report of 2 months earlier
danieldruff2
25/7/2017
11:44
Read the report, and all seems well, obviously there are several intangibles at this stage, that if all come to fruition, could make this a very big company!
jacobjohn7
25/7/2017
11:42
Collagen Solutions PLC Director/PDMR Shareholding 25/07/2017 11:36am UK Regulatory (RNS & others) Collagen Sol (LSE:COS) Intraday Stock Chart Today : Tuesday 25 July 2017 Click Here for more Collagen Sol Charts. TIDMCOS RNS Number : 0283M Collagen Solutions PLC 25 July 2017 This announcement contains inside information Collagen Solutions Plc (the "Company") Director/PDMR Dealing Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it was notified today that David Evans, Chairman of the Company, has purchased 900,000 ordinary shares in the Company ("Ordinary Shares") at 5.1 pence per Ordinary Share. Following the transaction, David Evans' total beneficial holding in the Company has increased to 39,394,554 Ordinary Shares representing 12.15 per cent. of the issued ordinary share capital of the Company. Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
jacobjohn7
12/7/2017
08:00
New Interview (and article) on Proactiveinvestor: http://www.proactiveinvestors.co.uk/companies/stocktube/7771/collagen-solutions-jamal-rushdie-hails-significant-growth-in-asia-pacific-europe-7771.html http://www.proactiveinvestors.co.uk/companies/news/180711/collagen-solutions-moves-up-the-medtech-value-chain-180711.html
timbo003
07/7/2017
12:53
Jamal Rushdy, CEO of Collagen Solutions said: "We are excited to begin the clinical assessment of long-term scaffold performance in patients who received the ChondroMimetic® implant. To our knowledge, ChondroMimetic® will be the only known, 'unpartnered' product with such long-term clinical evidence, significantly differentiating it from competing therapies. This extension study represents a critical step forward in our ChondroMimetic® development programme, which has the potential to address 450,000 annual cartilage procedures and provide access to a US $500M-$1B market opportunity via a novel, proprietary technology." There looks to be a very big market in the america alone.
slartybartfaster
28/6/2017
10:14
interesting slarty. I'm sure with the levels of stated expectations the company will over achieve slightly on forecasts. Reckon they will combine it with news of CE mark being obtained for chondromimetic. Wait and see as ever.
jacobjohn7
23/6/2017
19:48
I may well be talking to myself here. Blogger is expecting something special come 11th july. 2 weeks away and the share price looks jittery.
slartybartfaster
02/6/2017
21:34
In their half year report. They cross invest over more than one VCT as there are limits per VCT for investing in one company, here's one of the two vehicles investing: hTTp://www.investegate.co.uk/baronsmead-second-vt--bmd-/rns/half-year-report/201705240700090295G/ Incidentally these VCTs have a great record over the last 20 years or so of returning excellent dividends, though it can be lumpy.
danieldruff2
02/6/2017
17:19
well done, bounced it about today for buyers so why not! wheres info on baronsmead Dan?
jacobjohn7
02/6/2017
14:46
good buy jj.couldnt add again today, had to make land payment, buying a plot to build a house.
1toad
02/6/2017
11:35
I've added a few today. I hold shares in the Baronsmead VCT and it caught my eye that they had invested here. Then it caught my eye that the Northern VCT had also chosen to invest here, two votes of confidence from micro cap specialists has tempted me in.
danieldruff2
02/6/2017
11:24
20,000 shares @ 4.75 Good rock bottom price. happy to wait this one out ;o)
jacobjohn7
30/5/2017
14:17
Thanks jj, l added also.
1toad
26/5/2017
22:39
not me ashtree though i have added recently.
jacobjohn7
26/5/2017
13:19
Nice buy 10 grands worth,is that you JJ
ashtree2
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20171017 13:26:17